| 2VJ1 | B:29-301; B:29-301 | A STRUCTURAL VIEW OF THE INACTIVATION OF THE SARS-CORONAVIRUS MAIN PROTEINASE BY BENZOTRIAZOLE ESTERS |
| 2Q6G | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE |
| 2QC2 | B:29-305; B:29-305 | CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE ASN214ALA MUTANT |
| 2QCY | A:29-306 | CRYSTAL STRUCTURE OF A MONOMERIC FORM OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE MUTANT |
| 2QIQ | A:29-301 | STRUCTURE-BASED DESIGN AND SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC SARS-3CLPRO INHIBITORS |
| 2V6N | A:29-306 | CRYSTAL STRUCTURES OF THE SARS-CORONAVIRUS MAIN PROTEINASE INACTIVATED BY BENZOTRIAZOLE COMPOUNDS |
| 2Z3C | A:29-306 | A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE |
| 2Z3E | A:29-306 | A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE |
| 1Q2W | B:29-301; B:29-301 | X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE |
| 1UJ1 | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) |
| 1UK3 | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6 |
| 1UK4 | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR |
| 1WOF | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1 |
| 1Z1I | A:29-301 | CRYSTAL STRUCTURE OF NATIVE SARS CLPRO |
| 1Z1J | B:1029-1306; B:1029-1306 | CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT |
| 2OP9 | B:29-301; B:29-301 | SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS |
| 2Z94 | A:29-306 | COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH TDT |
| 2Z9G | A:29-306 | COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH PMA |
| 2Z9J | B:29-304; B:29-304 | COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH EPDTC |
| 2Z9K | B:29-306; B:29-306 | COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1600 |
| 2Z9L | B:29-301; B:29-301 | COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1586 |
| 3M3S | B:29-302; B:29-302 | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE ASN214ALA MUTANT WITH AUTHORIZE N-TERMINUS |
| 3M3T | A:29-305 | SARS-COV MAIN PROTEASE MONOMERIC ARG298ALA MUTANT WITH N-TERMINAL ADDITIONAL RESIDUES (GLY-SER) |
| 3M3V | B:29-303; B:29-303 | SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A WITH TWO N-TERMINAL ADDITIONAL RESIDUE (GLY-SER) |
)
)